The Clinical Study of the Efficacy and Safety of L-Carnitine Injection in Treatment of Heart Failure

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

268

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

March 31, 2012

Study Completion Date

March 31, 2012

Conditions
Heart Failure,
Interventions
DRUG

Levocarnitine Injection

Levocarnitine Injection:5ml:1g

DRUG

Levocarnitine placebo

L-Carnitine injection placebo (5ml:1g)

Trial Locations (1)

200433

Shanghai Pulmonary Hospital affiliated to Tongji University, Shanghai

Sponsors
All Listed Sponsors
lead

Lee's Pharmaceutical Limited

INDUSTRY